Glucocorticoids and the osteoclast

Annals of the New York Academy of Sciences

Volumn 1116, Issue , 2007, Pages 335-339

  Kim, Hyun Ju ^a   Zhao, Haibo ^a   Kitaura, Hideki ^a   Bhattacharyya, Sandip ^b   Brewer, Judson A ^b   Muglia, Louis J ^b   Patrick Ross, F ^a   Teitelbaum, Steven L ^a,b  

^a Department of Pathology and Immunology ^*  (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone remodeling; Glucocorticoids; Osteoclasts

Indexed keywords

COLONY STIMULATING FACTOR 1; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; RAC PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VAV PROTEIN; VAV3 PROTEIN;

BONE REMODELING; CELL DISRUPTION; CELL LINEAGE; CONFERENCE PAPER; CYTOSKELETON; HUMAN; IN VIVO STUDY; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; WILD TYPE;

MUS;

EID: 37249075921     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1402.057     Document Type: Conference Paper

References (11)

1. WEINSTEIN, R.S. 2001. Glucocorticoid-induced osteoporosis. Rev. Endocr. Metab. Disord. 2: 65-73.
2. RUBIN, M.R. & J.P. BILEZIKIAN. 2002. Clinical review 151: the role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a reexamination of the evidence. J. Clin. Endocrinol. Metab. 87: 4033-4041.
3. WEINSTEIN, R.S., R.L. JILKA, A.M. PARFITT, et al. 1998. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. J. Clin. Invest. 102: 274-282.
4. SMITH, E., R.A. REDMAN, C.R. LOGG, et al. 2000. Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes. J. Biol. Chem. 275: 19992-20001.
5. AUBIN, J.E. 1999. Osteoprogenitor cell frequency in rat bone marrow stromal populations: role for heterotypic cell-cell interactions in osteoblast differentiation. J. Cell. Biochem. 72: 396-410.
6. PURPURA, K.A., J.E. AUBIN & P.W. ZANDSTRA. 2004. Sustained in vitro expansion of bone progenitors is cell density dependent. Stem Cells 22: 39-50.
7. KIM, H.J., H. ZHAO, H. KITAURA, et al. 2006. Glucocorticoids suppress bone formation via the osteoclast. J. Clin. Invest. 116: 2152-2160.
8. WEINSTEIN, R.S., J.R. CHEN, C.C. POWERS, et al. 2002. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J. Clin. Invest. 109: 1041-1048.
9. TEITELBAUM, S.L. 2000. Bone resorption by osteoclasts. Science 289: 1504-1508.
10. TEITELBAUM, S.L. 2007. Osteoclasts: what do they do and how do they do it? Am. J. Pathol. 170: 427-435.
11. FACCIO, R., S.L. TEITELBAUM, K. FUJIKAWA, et al. 2005. Vav3 regulates osteoclast function and bone mass. Nat. Med. 11: 284-290.